Oligonucleotide decoys for the treatment of pain
US10683502B2 · kind B2 · utility
0Cited by
48References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2019 |
| Grant date | Jun 16, 2020 |
| Priority date | — |
| Expiry date | Mar 19, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are therapeutic agents such as double-stranded nucleic acids, termed oligonucleotide decoys, pharmaceutical compositions comprising the same, and related methods of modulating nociceptive signaling, for instance, to prevent and/or treat pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.